NanoViricides : Announces Completion of $10.2 Million Registered Direct Offering – Funds to Accelerate COVID-19 Drug Program and HerpeCide™ Program – Marketscreener.comBy / May 31, 2020 NanoViricides : Announces Completion of $10.2 Million Registered Direct Offering – Funds to Accelerate COVID-19 Drug Program and HerpeCide™ Program Marketscreener.com Share this:TweetReddit
